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Abstract
Background: A waterborne outbreak of Giardia lamblia gastroenteritis led to a high prevalance of long-lasting
fatigue and abdominal symptoms. The aim was to describe the clinical characteristics, disability and
employmentloss in a case series of patients with Chronic Fatigue Syndrome (CFS) after the infection.
Methods: Patients who reported persistent fatigue, lowered functional capacity and sickness leave or delayed
education after a large community outbreak of giardiasis enteritis in the city of Bergen, Norway were evaluated
with the established Centers for Disease Control and Prevention criteria for CFS. Fatigue was self-rated by the
Fatigue Severity Scale (FSS). Physical and mental health status and functional impairment was measured by the
Medical Outcome Severity Scale-short Form-36 (SF-36). The Hospital Anxiety and Depression Scale (HADS) was used
to measure co-morbid anxiety and depression. Inability to work or study because of fatigue was determined by
sickness absence certified by a doctor.
Results: A total of 58 (60%) out of 96 patients with long-lasting post-infectious fatigue after laboratory confirmed
giardiasis were diagnosed with CFS. In all, 1262 patients had laboratory confirmed giardiasis. At the time of referral
(mean illness duration 2.7 years) 16% reported improvement, 28% reported no change, and 57% reported
progressive course with gradual worsening. Mean FSS score was 6.6. A distinctive pattern of impairment was
documented with the SF-36. The physical functioning, vitality (energy/fatigue) and social functioning were
especially reduced. Long-term sickness absence from studies and work was noted in all patients.
Conclusion: After giardiasis enteritis at least 5% developed clinical characteristics and functional impairment
comparable to previously described post-infectious fatigue syndrome.
Background
Fatigue is a prominent symptom of many acute infec-
tions. In a minority of the infected individuals the per-
iod of convalescence is followed by a post-infectious
illness with disabling fatigue, musculoskeletal pain and
neurocognitive difficulties [1]. Both viral and non-viral
micro-organisms have a causative role in triggering a
chronic fatigue syndrome [2]. The functional and occu-
pational morbidity in these patients is considerable with
work-related disability reflected in long-term sickness
absence from studies and employment [3,4].
Giardia lamblia infections are rare in our area. How-
ever due to contamination of the municipal water sup-
ply in Bergen, Norway, in 2004, 1262 (764 females and
498 males) laboratory-confirmed cases of Giardia lam-
blia were registered [5,6]. All cases received a question-
naire in 2006 including the following concerning fatigue:
“ Do you have problems with fatigue?” (less or same as
usual/more than usual//much more than usual). The
last two answer options were defined as fatigue. The
response rate was 81% (1017/1262) and fatigue was
reported by 41% (419/1017) as compared to 22% in the
general population [7,8]. Patients with loss of employ-
ment or delayed education due to severe fatigue were
admitted to a specialist chronic fatigue clinic at the
Department of Neurology, Haukeland University Hospi-
tal, Bergen, Norway for clinical evaluation with Centers
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[9-11].
T h eg o a l so ft h ep r e s e n ts t u d yw e r et od e s c r i b et h e
clinical characteristics of CFS in this patient cohort and
to assess and document disability and the level of work
related impairment and loss of employment [4,9,12,13].
The course of the illness from onset of abdominal
symptoms due to Giardia enteritis to the development
of severe fatigue is of interest in order to evaluate of the
association between acute infection and the subsequent
severe fatigue. Previous studies have reported both sud-
den and gradual onset of illness [14-17]. The present
study aims to shed some light on this issue by describ-
ing the clinical picture of CFS following a common
infectious agent.
Giardia enteritis appears to have precipitated a small
outbreak of CFS previously [18]. To our knowledge this
is the first report of CFS after a large community out-
break of confirmed Giardia enteritis.
Methods
Patients
From August 2005 to September 2007, 96 patients (29
males and 67 females) with laboratory verified Giardia
lamblia infection during autumn 2004 were referred to a
specialist chronic fatigue clinic at the Department of
Neurology, Haukeland University Hospital for clinical
evaluation of severe long-lasting post-infectious fatigue
with functional impairment for work or studies. The
patients were either referred from general practitioners
in Bergen (5 cases) or from the Department of Medi-
cine, Haukeland University Hospital (91 cases). Primary-
care records were available and examined. In addition to
written self-report of past medical and psychiatric his-
tory the patients were interviewed about exclusionary
medical and psychiatric diagnosis (psychosis, bipolar dis-
order, substance misuse, an organic brain disorder, or
an eating disorder) by an experienced clinical neurolo-
gist. Patients fulfilling the CFS criteria [10] were
included in the present study and underwent further
evaluation as detailed below. We excluded patients with
an interval free of symptoms between the giardiasis
enteritis and the development of CFS.
All patients completed a checklist of symptoms for
details see Table 1. At the time of referral the patients
were asked to quantify abdominal symptoms (nausea,
bloating, abdominal pain, constipation, and diarrhea) on
a scale from 0 to 10 where 10 represented worst symp-
toms (Table 2). Social adversity and stressful life events
and difficulties such as disease or death in close family,
marital problems, financial problems, and occupational
stress based on self-report were recorded [19]. A shor-
tened Eysenck personality inventory neuroticism (EPQ-
N) scale was used [20].
Fatigue was self-rated by the Fatigue Severity Scale
(FSS) which consists of nine statements regarding fati-
gue experiences. Patients were asked whether they dis-
agreed (1) or agreed (7) using a Likert scale (range 1 to
7). Higher scores indicate higher levels of fatigue.
Patients with a mean FSS score > 5 are defined as hav-
ing severe fatigue [21,22].
Table 1 Symptoms at the time of referral (n = 58)
Total
n (%)
Females
n (%)
Males
n (%)
P*
Headache 41 (71) 32 (73) 9 (64) .74
Myalgia 40 (69) 33 (75) 7 (50) .10
Arthralgia 30 (52) 25 (57) 5 (36) .22
Flu-like symptoms 37 (64) 32 (73) 5 (36) .023
Frequent sore throat 27 (47) 23 (52) 4 (29) .14
Tender lymph nodes 11 (19) 9 (21) 2 (14) 1.00
Visual disturbances 22 (38) 18 (41) 4 (29) .53
Dizziness 42 (72) 33 (75) 9 (64) .50
Paresthesia 24 (41) 21 (48) 3 (21) .12
Muscle weakness 47 (81) 37 (84) 10 (71) .43
Photo/phonophobia 35 (60) 32 (73) 3 (21) .001
Reduced stress tolerance 52 (91) 42 (96) 10 (77) .072
Reduced sleep quality 37 (64) 29 (66) 8 (57) .75
Increased need of sleep 51 (89) 39 (89) 12 (86) 1.000
Depression 23 (40) 17 (39) 6 (43) 1.000
Anxiety 21 (37) 17 (40) 4 (29) .54
Concentration problems 56 (97) 43 (98) 13 (93) .43
Memory problems 45 (78) 37 (84) 8 (57) .06
Confusion 18 (32) 13 (30) 5 (39) .74
Word finding problems 36 (63) 28 (64) 8 (62) 1.00
Palpitations 24 (41) 20 (46) 4 (29) .36
Fainting 14 (25) 11 (25) 3 (23) 1.000
Respiratory problems 14 (25) 12 (27) 2 (15) .48
Frequent micturition during night 25 (44) 21 (48) 4 (31) .35
Changed temperature regulation 28 (49) 26 (59) 2 (15) .010
Night sweating 24 (42) 18 (41) 6 (46) .76
* Fisher’s exact test comparing females and males
Table 2 Mean abdominal symptom severity on referral
(range 0-10 (severe)) (n = 58)
Total Females Males P*
Nausea 2.8 3.2 1.9 .15
Bloating 5.2 5.7 3.6 .02
Abdominal pain 3.7 3.9 2.9 .23
Constipation 1.6 1.7 1.2 .51
Diarrea 3.8 3.9 3.5 .68
Mean abdominal complaints 3.4 3.7 2.6 .06
* Student’s t-test
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Page 2 of 7Time to fatigue after onset of enteritis was defined as
immediately, taking weeks, or months.
To assess functional impairment we used the Short-
Form Health Survey (SF-36). The SF-36 has eight sub-
scales: physical functioning (PF), role limitations due to
physical health problems (role-physical, RP), bodily pain
(BP), general health (GH), vitality (VT), social function-
ing (SF), role limitations due to emotional health pro-
blems (role-emotional, RE) and mental health (MH).
The first four sub-scales primarily measure physical
health and the last four primarily measure mental
health. A distinctive pattern of impairment has been
reported for CFS when patients in different countries
are evaluated [23]. Normative SF-36 data by gender and
age are available for the general population in Norway
[24].
The Hospital Anxiety and Depression Scale (HADS)
was used to evaluate anxiety and/or depression (HADS-A
and HADS-D subscales respectively) [25]. There are nor-
mative data from Swedish and English studies [26,27].
Inability to work or study was recorded as sickness
absence certified by a doctor or delayed education [28].
An important outcome question was the patients’ rat-
ing of overall worsening or improvement since the onset
of their symptoms: worsening, no change, or
improvement.
The study was approved by the local ethics committee.
Statistics
Students t-test, Mann-Whitney U test, Fisher’s exact
test, and Pearson Chi square were used when appropri-
ate. All analyses were preformed with SPSS 14.0 for
Windows. P values < .05 were considered statistically
significant.
Results
A total of 96 patients were referred to the fatigue clinic
at the Department of Neurology, Haukeland University
Hospital with prolonged fatigue and accompanying
symptoms. Fifty-eight (60%) patients, 20 students and 38
workers, fulfilled the criteria for CFS; 44 (76%) females
a n d1 4( 2 4 % )m a l e s( P =. 0 2 ,F i s h e r ’s exact test includ-
ing all patients with Giardia lamblia confirmed infection)
comprising 5% of the patients with laboratory confirmed
Giardia lamblia. The mean age at onset of the disease
for females was 35.3 years (SD 11.2) and for males 29.2
years (SD 11.7) (P = .09, Student’s t-test). The mean age
at the time of referral for females was 38.0 years (SD
11.3) and for males 31.7 years (SD 11.6) (P =. 0 7 ,S t u -
dent’s t-test). The mean duration of the illness was 2.7
years (SD .4; range 1.5 to 3.0 years). Table 3 shows sick-
ness absence among workers and students.
Table 1 shows the symptoms on referral for both
females and males. There were little differences between
the sexes. Females reported more severe abdominal
symptoms than males (P =. 0 6 ,F i s h e r ’se x a c tt e s t )
(Table 2).
Depression any time before the Giardia infection was
reported by 11/55 (20%) patients (mean time 10.8 years
before the Giardia infection). Anxiety any time before
the Giardia infection was reported by 9/55 (16%)
patients (only females) (mean time 15.5 years before the
Giardia infection). Table 4 shows stress episodes during
the 6 months prior to the Giardia infection. There were
more stressful life events prior to Giardia enteritis
among patients with fatigue development over months
compared to patients with fatigue development within
weeks (mean 1.1 events versus mean .6 events; P = .15,
Mann-Whitney U test).
Table 3 Patient demographics and employment status
Demographics
Female, n (%) 44 (76)
Age, mean, female 35.3
Age, mean, male 29.2
Education
< college degree, n (%) 14 (24)
college degree and post graduate, n (%) 44 (76)
Employment status (n = 38)
Working half-time, n (%) 13 (22)
Sickness absence, n (%) 22 (38)
Disability pension, n (%) 3 (5)
Education status (n = 20)
Studies half-time, n (%) 6 (10)
Sickness absence, n (%) 14 (24)
Table 4 The experience of life events and difficulties
during the 6 months prior to Giardia infection
Total
n (%)
Females
n (%)
Males
n (%)
P*
Diseases in close family 10
(18)
9 (21) 1 (8) .43
Education difficulties 10
(18)
7 (16) 3 (23) .68
Work difficulties 8 (14) 8 (18) 0 (0) .18
House or car difficulties 2 (4) 1 (2) 1 (8) .41
Death in distant family or among
friends
2 (4) 2 (5) 0 (0) 1.000
Financial difficulties 5 (9) 4 (9) 1 (8) 1.000
Death in close family 6 (11) 5 (11) 1 (8) 1.000
Disease in distant family or among
friends
2 (4) 2 (5) 0 (0) 1.000
Marital difficulties 4 (7) 3 (7) 1 (8) 1.000
Vacation difficulties 2 (4) 1 (2) 1 (8) .41
* Fisher’s exact test comparing females and males
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Page 3 of 7Time from onset of acute Giardia infection until
development of debilitating fatigue was reported as
acute among 16/58 (28%), taking weeks among 8/58
(14%) and taking months among 34/58 (58%). Patients
who developed debilitating fatigue over months had
more initial abdominal symptoms than patients who
developed debilitating fatigue within weeks of Giardia
enteritis (P = .06, Pearson Chi square).
At the time of referral 9/58 (16%) patients reported
improvement, 16/58 (28%) reported no change, and 33/
5 8( 5 7 % )r e p o r t e ds l i g h to rs i g n i f i c a n tw o r s e n i n g .T h e
mean fatigue score for FSS was 6.6 (SD .45). The mean
FSS score for females was 6.64 (SD .45) and for males
6.44 (SD .43) (P = .15, Student’s t-test).
Figure 1a, b show SF-36 subscale scores among
patients and controls for both sexes (n = 58). All sub-
scale scores were significantly reduced among patients
compared to controls for both sexes (all P < .001,
Mann-Whitney U test). The lowest scores were observed
for physical capacity, vitality and social functioning
while scores for emotional and mental functioning were
least reduced.
There were no differences between male and female as
to HADS-A (n = 58) sub-score, (7.4 versus 6.7, P =. 5 8 ,
Student’s t-test) or HADS-D (n = 57) sub-score (7.1 ver-
sus 7.5, P = .75, Student’s t-test). Compared to norma-
tive data from Sweden the patients scored higher for the
HADS-A sub-score (6.9 versus 5.3, P = .009, Student’st -
test) and for the HADS-D sub-score (7.4 versus 3.0, P <
.001, Student’s t-test)[26]. The HADS results show that
11 (22%) of the patients rated themselves at or beyond
the threshold of depression (HADS-D ≥ 11) and 13
(26%) of the patients for anxiety (HADS-A ≥ 11)[25].
Mean EPQ-N for males was 4.6 (SD 3.0) and for
females 5.1 (SD 2.8). These results did not differ from
normative data (P > .25, Student’s t-test) [20].
Discussion
Our study show that at least 5% of the patients with
confirmed Giardia enteritis reported failure to recover
with unexplained fatigue and accompanying symptoms
that in the broad corresponded with a clinical entity
described previously [9,10]. In comparison, the preva-
lence of CFS in a normal population ranges between
0.23% and 0.56% in different populations [29,30]. Thus,
the frequency of CFS among patients with confirmed
Giardia infection was at least 8 times higher than in the
general population. Our findings suggest that there may
be a relationship between Giardia infection and CFS.
However, further studies are needed to prove that there
is a causative relationship. Persisting abdominal com-
plaints classified as diarrhoea-predominant IBS were
present in 10% of the patients with confirmed Giardia
infection [6]. Similar prevalence rates of 5% with CFS
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Figure 1 a. Mean SF-36 subscores among female patiens on follow-up and female controls. b. Mean SF-36 subscores among male patiens
on follow-up and male controls. All P < .0001, Mann-Whitney U test.
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Page 4 of 7and 10% with IBS have been observed in patients after
campylobacter gastroenteritis [31]. The rate of post-
infectious fatigue syndrome after glandular fever has
been reported to be 9% in previous cohort studies
[2,32].
The patients in our cohort represent young adults not
exposed to Giardia lamblia before the contamination of
the municipal water in 2004. Although Giardia lamblia
is not an invasive parasite, proteins on the surface
induce a humoral immune reaction [33] and CFS patho-
genesis is likely to include immunologic components.
However, the relationship between inflammatory
responses and post-infectious fatigue syndrome have not
been documented in longitudinal studies [2].
In the present study the frequency of CFS was signifi-
cantly higher among females. Other studies have also
reported that CFS is more frequent among females
[9,34]. By contrast, there was no gender difference as to
the frequency of self-reported chronic fatigue two years
after disease onset among the laboratory confirmed
cases of Giardia lamblia in Bergen in accordance with
previous community-based studies of chronic fatigue [8].
There were little differences between the sexes both
regarding concomitant symptoms such as abdominal
symptoms and other symptoms in the early phase of the
disease. However, at the time of referral females
reported more severe abdominal symptoms (marginally
significant).
Although the cause of CFS is unknown it is generally
thought that post-infectious fatigue develops shortly
after acute infection [35,36]. However, more than half of
our patients had a gradual onset of fatigue. Other stu-
dies have shown conflicting results as to onset of symp-
toms [9,37]. We found that patients who developed
fatigue over months, tended to have more initial abdom-
inal symptoms than patients who developed fatigue
within weeks of Giardia enteritis. A possible explanation
is that many initial symptoms either masked the experi-
ence of early fatigue or the recall of early fatigue among
some patients. This may be of special importance in
cases of litigation where the timing of fatigue onset after
acute infection may determine the question of causation.
T h e r ew a sas l i g h tt r e n dt o w a r d sm o r es t r e s s f u ll i f e
events prior to Giardia enteritis among patients with
fatigue development over months compared to patients
with fatigue development within weeks [19]. A possible
interpretation is that whereas early onset of fatigue is
caused by the Giardia enteritis, late onset of fatigue
among some patients has more complex causation
including psychologically stressful life events present
before the Giardia enteritis [35].
The patients scored significantly worse than controls
on all subscale scores of SF-36 for both sexes. The
scores were lowest for physical functioning and vitality
whereas emotional and mental scores were only mildly
impaired. The scores among our patients were remark-
ably similar to the scores reported among patients with
CFS in a previous study [23]. This suggests a similar dis-
ease profile among our patients and patients with CFS
not related to Giardia enteritis and provides evidence
that CFS exists as a discrete illness characterised by
extremely low levels of physical functioning and only
mild mental and emotional components [15,38,39].
The patients scored significantly worse than the con-
trols both as to anxiety and depression based on the
HADS subscores [26]. There were no sex differences
between our patients as to HADS subscores. This is sur-
prising because no males reported anxiety any time
prior to disease onset while this was reported by 9
(21%) females. The CFS sufferers are not primarily
depressed, and do not exhibit illness behaviour [40].
Based on the inclusion criteria which included primary-
care records, the frequencies of depression and anxiety
among our patients based on HADS subscores do not
represent primary depression or anxiety, but reflect co-
morbid illness secondary to long-standing chronic fati-
gue. Others have found similar or higher HADS sub-
scores among patients with CFS [3,31,41]. Our patients
did not disclose any abnormal neuroticism.
CFS is associated with various functional limitations
both for work and social life, and assessment of func-
tional ability including sickness abscence is necessary in
medical and vocational rehabilitation [42]. The focus on
function ability represents a shift in attention from
symptoms to resources, possibilities and coping. After
the initial evaluation our patients entered a comprehen-
sive multidisciplinary intervention program. The pro-
gram was individualized and included education
focusing on psychology and coping. Rehabilitation
included physiotherapy, manageable exercise program,
and occupational therapy. We plan to publish a five year
follow-up study of the patients.
There has been one previous report of community
outbreak of CFS possibly precipitated by Giardia enteri-
tis comprising 11 patients [18]. The mean age was 31
years which is similar to the mean age in the present
study.
A limitation of the present study is that no systematic
search for CFS among all patients with confirmed Giar-
dia lamlia enteritis was performed. Thus, our findings
represent a lower limit for the frequency of CFS after
Giardia lamblia enteritis in a previously Giardia naïve
population. Another limitation is that we compared our
patients to published normative data and not a matched
control group recruited from Bergen. Data on diseases
and stressful events before the Giardia lamlia infection
were based on self-report and therefore liable to failure
of recall.
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In conclusion, among young, healthy adults never
exposed to Giardia lamblia a significant proportion
developed long-term chronic fatigue syndrome with
high rates of occupational disability. There is need for
the development of comprehensive rehabilitation
programs.
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